Tag: $Johnson & johnson

Johnson & Johnson stock was slipping Wednesday after the pharmaceutical company beat expectations for its second-quarter earnings.

Johnson & Johnson has agreed to pay $700 million to settle an investigation by 42 U.S. states and Washington, D.C. into its marketing of baby powder and other talc-based products blamed for allegedly causing cancer.

Johnson & Johnson reported first-quarter adjusted earnings that topped expectations as sales in its medical devices business surged.

Johnson & Johnson  agreed to acquire medical-devices maker Shockwave Medical  for a total enterprise value of about $13.1 billion.

Johnson & Johnson reported fourth-quarter earnings and revenue that narrowly edged out Wall Street’s expectations.

Johnson & Johnson said on Monday it had agreed to buy drug developer Ambrx Biopharma  for $2 billion to gain access to drugs that belong to a class of targeted cancer therapies which have drawn interest from other drugmakers.

Johnson & Johnson stock was edging higher after the pharmaceutical and medical-device company shared its long-term financial outlook.

Johnson & Johnson topped quarterly earnings and revenue estimates.

Johnson & Johnson on Wednesday forecast 12.5% growth in its annual adjusted profit after completing the separation of consumer health company Kenvue .

Johnson & Johnson on Thursday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations due to strong sales growth from the company’s medtech business.